These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10439359)

  • 1. The potential for monocyte-mediated immunotherapy during infection and malignancy--Part II: in vivo activation by exogenous cytokines and clinical applications.
    Williams MA; Rhoades CJ; Newland AC; Kelsey SM
    Leuk Lymphoma; 1999 Jul; 34(3-4):207-30. PubMed ID: 10439359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential for monocyte-mediated immunotherapy during infection and malignancy. Part I: apoptosis induction and cytotoxic mechanisms.
    Williams MA; Newland AC; Kelsey SM
    Leuk Lymphoma; 1999 Jun; 34(1-2):1-23. PubMed ID: 10350328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of human monocyte function against Candida albicans by the colony-stimulating factors (CSF): IL-3, granulocyte-macrophage-CSF, and macrophage-CSF.
    Wang M; Friedman H; Djeu JY
    J Immunol; 1989 Jul; 143(2):671-7. PubMed ID: 2661688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective phagocytosis by human monocyte/macrophages following HIV-1 infection: underlying mechanisms and modulation by adjunctive cytokine therapy.
    Kedzierska K; Azzam R; Ellery P; Mak J; Jaworowski A; Crowe SM
    J Clin Virol; 2003 Feb; 26(2):247-63. PubMed ID: 12600656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.
    Hübel K; Dale DC; Liles WC
    J Infect Dis; 2002 May; 185(10):1490-501. PubMed ID: 11992286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
    Feili-Hariri M; Falkner DH; Morel PA
    J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia.
    Emanuel PD; Bates LJ; Zhu SW; Castleberry RP; Gualtieri RJ; Zuckerman KS
    Exp Hematol; 1991 Nov; 19(10):1017-24. PubMed ID: 1915702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of in vivo administration of GM-CSF and G-CSF on monocyte cytotoxicity.
    Wiltschke C; Krainer M; Wagner A; Linkesch W; Zielinski CC
    Exp Hematol; 1995 May; 23(5):402-6. PubMed ID: 7536681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes.
    Sin JI; Kim JJ; Ugen KE; Ciccarelli RB; Higgins TJ; Weiner DB
    Eur J Immunol; 1998 Nov; 28(11):3530-40. PubMed ID: 9842896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation-dependent cell death of human monocytes is a novel mechanism of fine-tuning inflammation and autoimmunity.
    Däbritz J; Weinhage T; Varga G; Wirth T; Ehrchen JM; Barczyk-Kahlert K; Roth J; Schwarz T; Foell D
    Eur J Immunol; 2016 Aug; 46(8):1997-2007. PubMed ID: 27159026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7-1) expression.
    Ozawa H; Aiba S; Nakagawa ; Tagami H
    Eur J Immunol; 1996 Mar; 26(3):648-52. PubMed ID: 8605933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential modulation of B7-1 and B7-2 isoform expression on human monocytes by cytokines which influence the development of T helper cell phenotype.
    Creery WD; Diaz-Mitoma F; Filion L; Kumar A
    Eur J Immunol; 1996 Jun; 26(6):1273-7. PubMed ID: 8647204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Culture of human monocytes with granulocyte-macrophage colony-stimulating factor results in enhancement of IFN-gamma receptors but suppression of IFN-gamma-induced expression of the gene IP-10.
    Finbloom DS; Larner AC; Nakagawa Y; Hoover DL
    J Immunol; 1993 Mar; 150(6):2383-90. PubMed ID: 8450219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muramyl dipeptide and mononuclear cell supernatant induce Langhans-type cells from human monocytes.
    Mizuno K; Okamoto H; Horio T
    J Leukoc Biol; 2001 Sep; 70(3):386-94. PubMed ID: 11527988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel differentiation antigen on human monocytes that is specifically induced by granulocyte-macrophage colony-stimulating factor or IL-3.
    Maeda K; Sone S; Ohmoto Y; Ogura T
    J Immunol; 1991 Jun; 146(11):3779-84. PubMed ID: 1903413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination immunotherapy and antifungal chemotherapy.
    Stevens DA
    Clin Infect Dis; 1998 Jun; 26(6):1266-9. PubMed ID: 9636844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic activation of human monocytes by granulocyte-macrophage colony-stimulating factor and IFN-gamma. Increased TNF-alpha but not IL-1 activity.
    Hart PH; Whitty GA; Piccoli DS; Hamilton JA
    J Immunol; 1988 Sep; 141(5):1516-21. PubMed ID: 3137258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-4 suppresses granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in stimulated human monocytes.
    Hamilton JA; Whitty GA; Royston AK; Cebon J; Layton JE
    Immunology; 1992 Aug; 76(4):566-71. PubMed ID: 1383133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.